Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response (original) (raw)

References

• Adam, J. A. and N. Bellomo (1997). A Survey of Models for Tumor-Immune System Dynamics, Boston, MA: Birkhauser.
  MATH Google Scholar
• Bischoff, J. R. et al. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373–376.
  Article Google Scholar
• Coffey, M. C., J. E. Strong, P. A. Forsyth and P. W. K. Lee (1998). Reovirus therapy of tumors with activated Ras pathways. Science 282, 1332–1334.
  Article Google Scholar
• D’Argenio, D. Z. and A. Schumitzky (1997). Adapt II User’s Guide: Pharmacokinetic/Pharmacodynamics Systems Analysis Software, LosAngeles: University of Southern California, Biomedical Simulation Resource.
  Google Scholar
• Diekmann, O., J. A. P. Heesterbeek and J. A. J. Metz (1990). On the definition and the computation of the basic reproductive ratio R 0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28, 365–382.
  Article MathSciNet MATH Google Scholar
• Fowler, J. F. (1991). The phantom of tumor treatment—continually rapid proliferation unmasked. Radioth. Oncol. 22, 156–158.
  Article Google Scholar
• Ganly, I., D. Kirn, G. Eckhardt et al. (2000). A phase I study of Onyx-015, and E1B-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clinical Cancer Res. 6, 798–806.
  Google Scholar
• Greenspan, H. P. (1972). Models for the growth and stability of cell cultures and solid tumours. J. Theor. Biol. 56, 229–242.
  MathSciNet Google Scholar
• Heise, C., A. Sampson-Johannes, A. Williams, F. McCormick, D. D. Von Hoff and D. H. Kirn (1997). ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3, 639–642.
  Article Google Scholar
• Heise, C., A. Williams, J. Olesch and D. H. Kirn (1999a). Efficacy of a replication-competent adenovirus (ONYX-015) is associated with intratumoral distribution. Cancer Gene Therapy 6, 499–504.
  Article Google Scholar
• Heise, C. C., A. M. Williams, S. Xue, M. Propst and D. H. Kirn (1999b). Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. Cancer Res. 59, 2623–2628.
  Google Scholar
• Jain, R. (1994). Barriers to drug delivery in solid tumors. Sci. Am. 271, 58–65.
  Article Google Scholar
• Kendall, D. G. (1965). Mathematical models of the spread of infection, in Mathematics and Computer Science in Biology and Medicine, London: Medical Research Council, pp. 213–224.
  Google Scholar
• Khuri, F. R. et al. (2000). A controlled trial of ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879–885.
  Article Google Scholar
• Kirn, D., R. L. Martuza and J. Zweibel (2001). Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat. Med. 7, 781–787.
  Article Google Scholar
• Kuang, Y. (1993). Delay Differential Equations: with Applications to Population Dynamics, Boston: Academic Press.
  MATH Google Scholar
• Mollison, D. (1977). Spatial contact models for ecological and epidemic spread. J. R. Stat. Soc. B. 39, 283–326.
  MATH MathSciNet Google Scholar
• Nemunaitis, J. et al. (2000). Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res. 60, 6359–6366.
  Google Scholar
• O’Donoghue, J. A., M. Bardies and T. E. Wheldon (1995). Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J. Nuclear Med. 36, 1902–1909.
  Google Scholar
• Reid, T., E. Galanis, J. Abbruzzese, D. Sze, J. Andrews, L. Romel, M. Hatfield, J. Rubin and D. Kirn (2001). Intra-arterial administration of a replication-selective adenovirus (_dl_1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Theor. 8, 1618–1626.
  Article Google Scholar
• Reid, T. et al. (2002). Hepatic artery infusion of a replication-selective oncolytic adenovirus (_dl_1520): phase II viral, immunologic, and clinical endpoints. Cancer Res. 62, 6070–6079.
  Google Scholar
• Rodriguez, R., E. R. Schuur, H. Y. Lim, G. A. Henderson, J. W. Simons and D. R. Henderson (1997). Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cyto-toxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57, 2559–2563.
  Google Scholar
• Rogulski, K. R., S. O. Freytag, K. Zhang, J. D. Gilbert, D. L. Paielli, J. H. Kim, C. C. Heise and D. H. Kirn (2000). In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy. Cancer Res. 60, 1193–1196.
  Google Scholar
• Rubenštein, L. I. (1971). The Stefan problem. Translations of Math. Monographs 27, Providence, RI: American Mathematical Society.
  Google Scholar
• Swabb, E. A., J. Wei and P. M. Gullino (1974). Diffusion and convection in normal and neoplastic tissues. Cancer Res. 34, 2814–2822.
  Google Scholar
• Takeuchi, Y., N. Adachi and H. Tokumaru (1978). The stability of generalized Volterra equations. J. Math. Anal. Appl. 62, 453–473.
  Article MathSciNet MATH Google Scholar
• Takeuchi, Y. and N. Adachi (1980). The existence of globally stable equilibria of ecosystems of the generalized Volterra type. J. Math. Biol. 10, 410–415.
  Article MathSciNet Google Scholar
• Tao, Y. and Q. Guo (2003). The Competitive Dynamics Between Tumor Cells, a Replication-competent Virus and an Immune Response, Shanghai, PR China: Department of Applied Mathematics, Dong Hua University.
  Google Scholar
• Ward, J. P. and J. R. King (1997). Mathematical modelling of avascular-tumour growth. IMA J. Math. Med. Appl. Biol. 14, 39–70.
  MATH Google Scholar
• Wein, L. M., J. T. Wu and D. H. Kirn (2003). Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res. 63, 1317–1324.
  Google Scholar
• Wodarz, D. (2001). Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Res. 61, 3501–3507.
  Google Scholar
• Wu, J. T., H. M. Byrne, D. H. Kirn and L. M. Wein (2001). Modeling and analysis of a virus that replicates selectively in tumor cells. Bull. Math. Biol. 63, 731–768.
  Article Google Scholar
• Yoon, S. S., N. M. Carroll, E. A. Chiocca and K. K. Tanabe (1998). Cancer gene therapy using a replication-competent herpes simplex virus type I vector. Ann. Surgery 228, 366–374.
  Article Google Scholar
• Yu, D., Y. Chen, J. Dilley, Y. Li, M. Embry, H. Zhang, P. Amin, J. Oh and D. Henderson (2001). Antitumor synergy of CN787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. Cancer Res. 61, 517–525.
  Google Scholar

Download references